Β3‐Adrenergic Regulation of EPC Features Through Manipulation of the Bone Marrow MSC Niche. Issue 12 (12th June 2017)

• Record Type: Journal Article
• Authors: Vafaei, Rana; Nassiri, Seyed Mahdi; Siavashi, Vahid
• Is Part Of: Journal of cellular biochemistry. Volume 118:Issue 12(2017)
• Page Start: 4753
• Page End: 4761
• Publication Date: 2017-06-12
• Subjects: EPC -- MSC -- NICHE -- β3‐ADRENERGIC; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.26143
• Languages: English
• ISSNs: 0730-2312

Abstract

ABSTRACT: Mesenchymal stem cells (MSCs) reside in a specific niche in the bone marrow, however, biological features of this niche are still not fully understood. Given the interactions of MSCs with endothelial cells in different tissues, bone marrow MSC niche may influence the biological features of endothelial progenitor cells (EPCs). To understand the role of the sympathetic nervous system in regulation of the MSC niche, we examined whether the manipulation of the MSC niche via β3‐adrenergic signals will affect EPC features. A selective β3 agonist (BRL37344) or a β3 antagonist (SR59230A) was administered in mice for 2 weeks to determine the potential effects of these regimens on the population of CD133 + stem cells in the bone marrow. Then, bone marrow‐derived MSCs and EPCs were harvested and expanded from the mice to examine the effect of changes in the MSC niche on EPC features. Improved MSC colony forming potency with increased bone marrow stromal cell‐derived factor 1 (SDF‐1) (also known as C‐X‐C motif chemokine 12 [CXCL12]) expression was shown as a result of intensification of the bone marrow adrenergic signals through BRL37344 injection. On the other hand, the blockage of these signals limited the expression level of SDF‐1 and resulted in bone marrow enrichment of CD133 + cells. Manipulation of the MSC niche and decreased SDF‐1 expression via SR59230A injection also prompted EPCs to form more colonies with augmented proliferation and differentiation capacity. Overall, our results indicate that the β3‐adrenergic signals regulate the MSC niche, thereby resulting in modulation of EPC biological features. J. Cell. Biochem. 118: 4753–4761, 2017. © 2017 Wiley Periodicals, Inc. Abstract : Manipulation of MSC niche via β3 agonist, BRL37344 or β3 antagonist, SR59230A can modify the biological features of EPCs through changes in the expression level of SDF‐1.